Copyright Reports & Markets. All rights reserved.

Global Inhalational Isoflurane Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inhalational Isoflurane Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Generic Drugs
    • 1.3.3 Brand Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inhalational Isoflurane Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Inhalational Isoflurane Market Size & Forecast
    • 1.5.1 Global Inhalational Isoflurane Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Inhalational Isoflurane Sales Quantity (2021-2032)
    • 1.5.3 Global Inhalational Isoflurane Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 KALBE PHARMA
    • 2.1.1 KALBE PHARMA Details
    • 2.1.2 KALBE PHARMA Major Business
    • 2.1.3 KALBE PHARMA Inhalational Isoflurane Product and Services
    • 2.1.4 KALBE PHARMA Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 KALBE PHARMA Recent Developments/Updates
  • 2.2 Baxter
    • 2.2.1 Baxter Details
    • 2.2.2 Baxter Major Business
    • 2.2.3 Baxter Inhalational Isoflurane Product and Services
    • 2.2.4 Baxter Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Baxter Recent Developments/Updates
  • 2.3 Neon Laboratories
    • 2.3.1 Neon Laboratories Details
    • 2.3.2 Neon Laboratories Major Business
    • 2.3.3 Neon Laboratories Inhalational Isoflurane Product and Services
    • 2.3.4 Neon Laboratories Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Neon Laboratories Recent Developments/Updates
  • 2.4 AbbVie
    • 2.4.1 AbbVie Details
    • 2.4.2 AbbVie Major Business
    • 2.4.3 AbbVie Inhalational Isoflurane Product and Services
    • 2.4.4 AbbVie Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AbbVie Recent Developments/Updates
  • 2.5 Piramal
    • 2.5.1 Piramal Details
    • 2.5.2 Piramal Major Business
    • 2.5.3 Piramal Inhalational Isoflurane Product and Services
    • 2.5.4 Piramal Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Piramal Recent Developments/Updates
  • 2.6 LAB UNKNOWN
    • 2.6.1 LAB UNKNOWN Details
    • 2.6.2 LAB UNKNOWN Major Business
    • 2.6.3 LAB UNKNOWN Inhalational Isoflurane Product and Services
    • 2.6.4 LAB UNKNOWN Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 LAB UNKNOWN Recent Developments/Updates
  • 2.7 Viatris
    • 2.7.1 Viatris Details
    • 2.7.2 Viatris Major Business
    • 2.7.3 Viatris Inhalational Isoflurane Product and Services
    • 2.7.4 Viatris Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Viatris Recent Developments/Updates
  • 2.8 PT Novell Pharmaceutical
    • 2.8.1 PT Novell Pharmaceutical Details
    • 2.8.2 PT Novell Pharmaceutical Major Business
    • 2.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Product and Services
    • 2.8.4 PT Novell Pharmaceutical Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 PT Novell Pharmaceutical Recent Developments/Updates
  • 2.9 Sedana Medical
    • 2.9.1 Sedana Medical Details
    • 2.9.2 Sedana Medical Major Business
    • 2.9.3 Sedana Medical Inhalational Isoflurane Product and Services
    • 2.9.4 Sedana Medical Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sedana Medical Recent Developments/Updates
  • 2.10 Lunan Beite
    • 2.10.1 Lunan Beite Details
    • 2.10.2 Lunan Beite Major Business
    • 2.10.3 Lunan Beite Inhalational Isoflurane Product and Services
    • 2.10.4 Lunan Beite Inhalational Isoflurane Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lunan Beite Recent Developments/Updates

3 Competitive Environment: Inhalational Isoflurane by Manufacturer

  • 3.1 Global Inhalational Isoflurane Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Inhalational Isoflurane Revenue by Manufacturer (2021-2026)
  • 3.3 Global Inhalational Isoflurane Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Inhalational Isoflurane by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Inhalational Isoflurane Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Inhalational Isoflurane Manufacturer Market Share in 2025
  • 3.5 Inhalational Isoflurane Market: Overall Company Footprint Analysis
    • 3.5.1 Inhalational Isoflurane Market: Region Footprint
    • 3.5.2 Inhalational Isoflurane Market: Company Product Type Footprint
    • 3.5.3 Inhalational Isoflurane Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inhalational Isoflurane Market Size by Region
    • 4.1.1 Global Inhalational Isoflurane Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Inhalational Isoflurane Consumption Value by Region (2021-2032)
    • 4.1.3 Global Inhalational Isoflurane Average Price by Region (2021-2032)
  • 4.2 North America Inhalational Isoflurane Consumption Value (2021-2032)
  • 4.3 Europe Inhalational Isoflurane Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Inhalational Isoflurane Consumption Value (2021-2032)
  • 4.5 South America Inhalational Isoflurane Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Inhalational Isoflurane Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 5.2 Global Inhalational Isoflurane Consumption Value by Type (2021-2032)
  • 5.3 Global Inhalational Isoflurane Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 6.2 Global Inhalational Isoflurane Consumption Value by Application (2021-2032)
  • 6.3 Global Inhalational Isoflurane Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 7.2 North America Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 7.3 North America Inhalational Isoflurane Market Size by Country
    • 7.3.1 North America Inhalational Isoflurane Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Inhalational Isoflurane Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 8.2 Europe Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 8.3 Europe Inhalational Isoflurane Market Size by Country
    • 8.3.1 Europe Inhalational Isoflurane Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Inhalational Isoflurane Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Inhalational Isoflurane Market Size by Region
    • 9.3.1 Asia-Pacific Inhalational Isoflurane Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Inhalational Isoflurane Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 10.2 South America Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 10.3 South America Inhalational Isoflurane Market Size by Country
    • 10.3.1 South America Inhalational Isoflurane Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Inhalational Isoflurane Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inhalational Isoflurane Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Inhalational Isoflurane Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Inhalational Isoflurane Market Size by Country
    • 11.3.1 Middle East & Africa Inhalational Isoflurane Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Inhalational Isoflurane Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Inhalational Isoflurane Market Drivers
  • 12.2 Inhalational Isoflurane Market Restraints
  • 12.3 Inhalational Isoflurane Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inhalational Isoflurane and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inhalational Isoflurane
  • 13.3 Inhalational Isoflurane Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inhalational Isoflurane Typical Distributors
  • 14.3 Inhalational Isoflurane Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Inhalational Isoflurane market size was valued at US$ 22.42 million in 2025 and is forecast to a readjusted size of US$ 29.51 million by 2032 with a CAGR of 4.1% during review period.
    Isoflurane is a widely used inhalational anesthetic agent employed in general anesthesia. It is a halogenated ether with the chemical formula C₃H₂ClF₅O, and it functions by inducing a reversible loss of consciousness and sensation in patients undergoing surgical procedures. Isoflurane acts on the central nervous system by enhancing the inhibitory effects of neurotransmitters and disrupting neural pathways that mediate awareness and sensation. It is favored in clinical settings due to its stable cardiovascular effects, ease of control, and minimal metabolism by the liver. Its administration requires specialized equipment to ensure accurate delivery and maintenance of the desired anesthetic depth.
    This report is a detailed and comprehensive analysis for global Inhalational Isoflurane market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Inhalational Isoflurane market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhalational Isoflurane market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhalational Isoflurane market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhalational Isoflurane market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Inhalational Isoflurane
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Inhalational Isoflurane market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, LAB UNKNOWN, Viatris, PT Novell Pharmaceutical, Sedana Medical, Lunan Beite, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Inhalational Isoflurane market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Generic Drugs
    Brand Drug
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    KALBE PHARMA
    Baxter
    Neon Laboratories
    AbbVie
    Piramal
    LAB UNKNOWN
    Viatris
    PT Novell Pharmaceutical
    Sedana Medical
    Lunan Beite
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Inhalational Isoflurane product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Inhalational Isoflurane, with price, sales quantity, revenue, and global market share of Inhalational Isoflurane from 2021 to 2026.
    Chapter 3, the Inhalational Isoflurane competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Inhalational Isoflurane breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inhalational Isoflurane market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Inhalational Isoflurane.
    Chapter 14 and 15, to describe Inhalational Isoflurane sales channel, distributors, customers, research findings and conclusion.

    Buy now